Menu
1-702-720-6310 info@microcapspecualtors.com

Undervalued Cannabis and Biotech Firms

  • September 10, 2018

The most valuable sector of the Cannabis Industry may just be the extract of Cannabidiol (CBD), which has transformed into a wide variety of products ranging from health supplements to pet products. CBD based products have generated billions in revenue…

Read More

Cannabis and Biotech Firms Uptrending

  • September 10, 2018

A fascinating biotech firm DCTH (Delcath Systems, Inc.), has an intriguing treatment for liver cancer.  The company has initiated a global Phase 3 clinical trial for patients with intrahepatic cholangiocarcinoma (ICC), using its drug product Melphalan/HDS.  DCTH reported that the…

Read More

Cannabis and Biotech Stocks on High Alert

With Cannabis and biotechnology companies currently being the talk of the town, we believe we have located some very interesting firms that present lasting opportunities.  Just a couple weeks ago now Cannabis went mainstream with STZ investing $4 Billion into…

Read More
Search